Belgian contract development and manufacturing organisation Ardena Group has completed the acquisition of Netherlands-based bioanalytical contract laboratory services provider Analytical Biochemical Laboratory.
The acquisition enables Ardena to expand its pre-clinical and clinical offerings.
Sumitomo Chemical plans to acquire 20% stake in nucleic acid medicines developer Bonac for CNY4bn ($35.64m).
“Sumitomo Chemical plans to acquire 20% stake in nucleic acid medicines developer Bonac for CNY4bn ($35.64m).”
The acquisition will enable Bonac to expand its new drug development and manufacturing business.
Both the acquirer and target companies are based in Japan.
Share this article
